Prevention of asthma: where are we in the 21st century?

Phaedra Propp1, Allan Becker

  • 1The Manitoba Institute of Child Health, Winnipeg, MB R3E 3P4, Canada.

Insights

Asthma prevention requires multifaceted interventions targeting gene-environment interactions during pregnancy and early life. Understanding these factors offers insights into personalized asthma prevention strategies.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Health
  • Genetic Epidemiology

Background:

  • Childhood asthma has reached epidemic proportions, driven by complex gene-environment interactions.
  • A critical 'window of opportunity' exists during pregnancy and early life for environmental influences on asthma development.
  • Asthma prevalence may signal increased population risk for other chronic non-communicable autoimmune diseases.

Observation:

  • Multiple environmental, biologic, and sociologic factors are implicated in asthma development.
  • Meta-analyses indicate that multifaceted interventions are necessary for effective asthma prevention.
  • Studies on allergen reduction have demonstrated clinical benefits.

Findings:

  • Asthma arises from a dysfunctional interplay between an individual's genes and their environment, particularly during fetal and early infant stages.
  • Effective asthma prevention necessitates a comprehensive approach addressing various contributing factors.
  • Early life environmental exposures significantly influence the trajectory of asthma development.

Implications:

  • Further understanding of gene-environment interactions is crucial for developing personalized asthma prevention strategies.
  • Multifaceted interventions, including allergen reduction, show promise in clinical settings.
  • Research into asthma's developmental origins can inform broader public health strategies for chronic disease prevention.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
311
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K